A case for the genotoxicity of ochratoxin a by bioactivation and covalent DNA adduction

Chemical Research in Toxicology

Volumn 18, Issue 7, 2005, Pages 1091-1097

  Manderville, Richard A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OCHRATOXIN;

BIOTRANSFORMATION; CARCINOGENESIS; DNA ADDUCT; DNA DAMAGE; FOOD CONTAMINATION; GENOTOXICITY; HUMAN; NONHUMAN; OXIDATIVE STRESS; RAT; REVIEW; TOXIN ANALYSIS;

ANIMALS; DNA ADDUCTS; HUMANS; MODELS, BIOLOGICAL; MUTAGENS; OCHRATOXINS;

EID: 22544454436     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050070p     Document Type: Review

References (79)

1. Kuiper-Goodman, T., and Scott, P. M. (1989) Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 2, 179-248.
2. Pohland, A. E., Nesheim, S., and Friedman, L. (1992) Ochratoxin A: A review. Pure Appl. Chem. 64, 1029-1046.
3. Monaci, L., and Palmisano, F. (2004) Determination of ochratoxin A in foods: State-of-the-art and analytical challenges. Anal. Bioanal. Chem. 378, 96-103.
4. Dai, J., Park, G., Perry, J. L., Il'ichev, Y. V., Bow, D. A. J., Pritchard, J. B., Faucet, V., Pfohl-Leszkowicz, A., Manderville, R. A., and Simon, J. D. (2004) Molecular aspects of the transport and toxicity of ochratoxin A. Acc. Chem. Res. 37, 874-881.
5. WHO (1996) Ochratoxin A-Toxicological Evaluation of Certain Food Additives and Contaminants, WHO Food Additives Series 35, pp 363-376, World Health Organization, Geneva.
6. Boorman, G., Ed. (1989) NTP technical report on the toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). NIH Publication No. 89-2813, U.S. Department of Health and Human Services, National Institutes of Health, Research Triangle Park, NC.
7. Castegnaro, M., Mohr, U., Pfohl-Leszkowicz, A., Estève, J., Steinmann, J., Tillman, J., Michelon, J., and Bartsch, H. (1998) Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 77, 70-75.
8. IARC (1993) Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monogr. Eval. Carcinog. Risks Hum. 56, 489-524.
9. Pfohl-Leszkowicz, A., Petkova-Bocharova, T., Chernozemsky, I. N., and Castegnaro, M. (2002) Balkan endemic nephropathy and the associated urinary tract tumors: Review on etiological causes, potential role of mycotoxins. Food Addit. Contam. 19, 282-302.
10. Vrabcheva, T., Petkova-Bocharova, T., Grosso, F., Nikolov, I., Chernozemsky, I. N., Castegnaro, M., and Dragacci, S. (2004) Analysis of ochratoxin A in foods consumed by inhabitants from an area with Balkan endemic nephropathy: a 1 month follow-up study. J. Agric. Food Chem. 52, 2404-2410.
11. European Union (2002) Task 3.2.7. Assessment of Dietary Intake of Ochratoxin A by the Population of EU Member States (Miraglia, M., and Brera, C., Eds.) p 82, EU Reports, Brussels, Belgium.
12. WHO (2002) JECFA Report from 56th Meeting: Evaluation of Certain Mycotoxins in Food, WHO Technical Report Series 906, WHO, Geneva, Switzerland.
13. Størmer, F. C. (1992) Ochratoxin A: A mycotoxin of concern. In Handbook of Applied Mycology (Bhatnagar, D., Lillehoj, E. B., and Arora, D. K., Eds.) pp 403-432, Marcel Dekker, New York.
14. Hietanen, E., Malaveille, C., Camus, A. M., Béréziat, J. C., Brun, G., Castegnaro, M., Michelon, J., Idle, J. R., and Bartsch, H. (1986) Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Drug Metab. Dispos. 14, 118-126.
15. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Gharbi, A., Baudrimont, I., Obrecht, S., Creppy, E. E., and Dirheimer, G. (1993) Is the oxidative pathway implicated in the genotoxicity of ochratoxin A? Human Ochratoxicosis and Its Pathologies, Vol. 231, pp 129-140, John Libbey Eurotext Ltd.
16. Størmer, F. C., Støren, O., Hansen, C. E., Pedersen, J. I., and Aasen, A. J. (1983) Formation of (4R)- and (4S)-4-hydroxyochratoxin A and 10-hydroxyochratoxin A from ochratoxin A by rabbit liver microsomes. Appl. Environ. Microbiol. 45, 1183-1187.
17. Pinelli, E., El Adlouni, C., Pipy, B., Quartulli, F., and Pfohl-Leszkowicz, A. (1999) Respective implication of cyclooxygenase and lipoxygenase in ochratoxin A genotoxicity on human epithelial lung cells. Environ. Toxicol. Pharmacol. 7, 95-107.
18. Grosse, Y., Baudrimont, I., Castegnaro, M., Betbeder, A.-M., Creppy, E. E., Dirheimer, G., and Pfohl-Leszkowicz, A. (1995) Formation of ochratoxin A metabolites and DNA adducts in monkey kidney cells. Chem.-Biol. Interact. 95, 175-187.
19. Grosse, Y., Monje, M. C., Macé, K., Pfeifer, A., and Pfohl-Leszkowicz, A. (1997) Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of ochratoxin A. In Vitro Toxicology 10, 93-102.
20. El Adlouni, C., Pinelli, E., Azémar, B., Zaoui, D., Beaune, P., and Pfohl-Leszkowicz, A. (2000) Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: Role of CYP 2C9 and microsomal glutathione-S-transferase. Environ. Mol. Mutagen. 35, 123-131.
21. Petkova-Bocharova, T., El Adlouni, C., Faucet, V., Pfohl-Leszkowicz, A., and Mantle, P. (2003) Analysis for DNA adducts, ochratoxin A content and enzymes expression in kidneys of pigs exposed to mild experimental chronic ochratoxicosis. Facta Univ., Ser.: Med. Biol. 10, 111-115.
22. Zepnik, H., Voelkel, W., and Dekant, W. (2003) Toxicokinetics of the mycotoxin ochratoxin A in F344 rats after oral administration. Toxicol. Appl. Pharmacol. 192, 36-44.
23. Li, S., Marquardt, R. R., Frohlich, A. A., Vitti, T. G., and Crow, G. (1997) Pharmacokinetics of ochratoxin A and its metabolites in rats. Toxicol. Appl. Pharmacol. 145, 82-90.
24. Mally, A., Keim-Heusler, H., Amberg, A., Kurz, M., Zepnik, H., Mantle, P., Völkel, W., Hard, G. C., and Dekant, W. (2005) Biotransformation and nephrotoxicity of ochratoxin B in rats. Toxicol. Appl. Pharmacol. In press.
25. Gautier, J.-C., Richoz, J., Welti, D. H., Markovik, J., Gremaud, E., Guengerich, F. P., and Turesky, R. J. (2001) Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes. Chem. Res. Toxicol. 14, 34-45.
26. Gross-Steinmeyer, K., Weymann, J., Hege, H.-G., and Metzler, M. (2002) Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes. J. Agric. Food Chem. 50, 938-945.
27. Mally, A., Zepnik, H., Wanek, P., Eder, E., Dingley, K., Ihmels, H., Völkel, W., and Dekant, W. (2004) Ochratoxin A: Lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 17, 234-242.
28. Stander, M. A., Steyn, P. S., van der Westhuizen, F. H., and Payne, B. E. (2001) A kinetic study into the hydrolysis of the ochratoxins and analogues by carboxypeptidase A. Chem. Res. Toxicol. 14, 302-304.
29. Malaveille, C., Brun, G., and Bartsch, H. (1991) Genotoxicity of ochratoxin A and structurally related compounds in Escherichia coli strains: Studies on their mode of action. IARC Sci. Publ. 261-266.
30. Malaveille, C., Brun, G., and Bartsch, H. (1994) Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites. Mutat. Res. 307, 141-147.
31. Calcutt, M. W., Gillman, I. G., Noftle, R. E., and Manderville, R. A. (2001) Electrochemical oxidation of ochratoxin A: Correlation with 4-chlorophenol. Chem. Res. Toxicol. 14, 1266-1272.
32. Gillman, I. G., Clark, T. N., and Manderville, R. A. (1999) Oxidation of ochratoxin A by an Fe-porphyrin system: Model for enzymatic activation and DNA cleavage. Chem. Res. Toxicol. 12, 1066-1076.
33. Manderville, R. A., Calcutt, M. W., Dai, J., Park, G., Gillman, I. G., Noftle, R. E., Mohammed, A. K., Dizdaroglu, M., Rodriguez, H., and Akman, S. A. (2003) Stoichiometric preference in copper-promoted oxidative DNA damage by ochratoxin A. J. Inorg. Biochem. 95, 87-96.
34. Dai, J., Park, G., Wright, M. W., Adams, M., Akman, S. A., and Manderville, R. A. (2002) Detection and characterization of a glutathione conjugate of ochratoxin A. Chem. Res. Toxicol. 15, 1581-1588.
35. Gillman, I. G., Yezek, J. M., and Manderville, R. A. (1998) Ochratoxin A acts as a photoactivatable DNA cleaving agent. Chem. Commun. 467-468.
36. Brow, M. E., Dai, J., Park, M. W., Wright, M. W., Gillman, I. G., and Manderville, R. A. (2002) Photochemically catalyzed reaction of ochratoxin A with D- and L-cysteine. Photochem. Photobiol. 76, 649-656.
37. Il'ichev, Y. V., Perry, J. L., Manderville, R. A., Chignell, C. F., and Simon, J. D. (2001) The pH-dependent primary photoreactions of ochratoxin A. J. Phys. Chem. B 105, 11369-11376.
38. Grabner, G., Richard, C., and Köhler, G. (1994) Formation and reactivity of 4-oxocyclohexa-2,5-dienylidene in the photolysis of 4-chlorophenol in aqueous solution at ambient temperature. J. Am. Chem. Soc. 116, 11470-11480.
39. Guengerich, F. P. (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 14, 611-650.
40. Van Dyke, R. A., and Gandolfi, A. J. (1976) Anaerobic release of fluoride from halothane. Relationship to the binding of halothane to hepatic cellular constituents. Drug Metab. Dispos. 4, 40-44.
41. Hayden, P. J., Ichimura, T., McCann, D. J., Pohl, L. R., and Stevens, J. L. (1991) Detection of cysteine conjugate metabolite adduct formation with specific mitochondrial proteins using antibodies raised against halothane metabolite adducts. J. Biol. Chem. 266, 18415-18418.
42. Kamp, H. G., Eisenbrand, G., Schlatter, J., Wurth, K., and Janzowski, C. (2005) Ochratoxin A: Induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 206, 413-425.
43. Goldman, R., Claycamp, G. H., Sweetland, M. A., Sedlov, A. V., Tyurin, V. A., Kisin, E. R., Tyurina, Y. Y., Ritov, V. B., Wenger, S. L., Grant, S. G., and Kagan, V. (1999) Myeloperoxidase-catalyzed redox-cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells. Free Radical Biol. Med. 27, 1050-1063.
44. Rietjens, I. M. C. M., den Besten, C., Hanzlink, R. P., and van Bladeren, P. J. (1997) Cytochrome P450-catalyzed oxidation of halobenzene derivatives. Chem. Res. Toxicol. 10, 629-635.
45. Dai, J., Wright, M. W., and Manderville, R. A. (2003) An oxygen-bonded C8-deoxy-guanosine nucleoside adduct of pentachlorophenol by peroxidase activation: evidence for ambident CS reactivity by phenoxyl radicals. Chem. Res. Toxicol. 16, 817-821.
46. Dai, J., Sloat, A. L., Wright, M. W., and Manderville, R. A. (2005) Role of phenoxyl radicals in DNA adduction by chlorophenol xenobiotics following peroxidase activation. Chem. Res. Toxicol. 18, 771-779.
47. Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and Monks, T. J. (2000) Role of quinones in toxicology. Chem. Res. Toxicol. 13, 135-160.
48. 8-aryladenine formation in calf thymus DNA from arenediazonium ions. Chem. Res. Toxicol. 12, 297-304.
49. Kohda, K., Tsunomoto, H., Kasamatsu, T., Sawamura, F., Terashima, I., and Shibutani, S. (1997) Synthesis and miscoding specificity of oligodeoxynucleotide containing 8-phenyl-2́-deoxyguanosine. Chem. Res. Toxicol. 10, 1351-1358.
50. Creppy, E. E., Kane, A., Dirheimer, G., Lafarge-Frayssinet, C., Mousset, S., and Frayssinet, C. (1985) Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol. Lett. 28, 29-35.
51. Lebrun, S., and Föllmann, W. (2002) Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay). Arch. Toxicol. 75, 734-741.
52. Pfohl-Leszkowicz, A., Bartsch, H., Azémar, B., Mohr, U., Estève, J., and Castegnaro, M. (2002) MESNA protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facia Univ., Ser.: Med. Biol. 9, 57-63.
53. Ozcelik, N., Soyoz, M., and Kilinc, I. (2004) Effects of ochratoxin A on oxidative damage in rat kidney: Protective role of melatonin. J. Appl. Toxicol. 24, 211-215.
54. Russo, A., La Fauci, L. L., Acquaviva, R., Campisi, A., Raciti, G., Scifo, C., Renis, M., Galvano, G., Vanella, A., and Galvano, F. (2005) Ochratoxin A-induced DNA damage in human fibroblast: Protective effect of cyanidin 3-O-β-D-glucoside. J. Nutr. Biochem. 16, 31-37.
55. Rahimtula, A. D., Bereziat, J. C., Bussacchini-Griot, V., and Bartsch, H. (1988) Lipid peroxidation as a possible cause of ochratoxin toxicity. Biochem. Pharmacol. 37, 4469-4477.
56. Gautier, J.-C., Holzhaeuser, D., Markovic, J., Gremaud, E., Schilter, B., and Turesky, R. J. (2001) Oxidative damage and stress response from ochratoxin A exposure in rats. Free Radical Biol. Med. 30, 1089-1098.
57. Schaaf, G. J., Nijmeijer, S. M., Maas, R. F., Roestenberg, P., de Groene, E. M., and Fink-Gremmels, J. (2002) The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim. Biophys. Acta 1588, 149-158.
58. Hoehler, D., Marquardt, R. R., McIntosh, A. R., and Xiao, H. (1996) Free radical generation as induced by ochratoxin A and its analogues in bacteria (Bacillus brevis). J. Biol. Chem. 271. 27388-27394.
59. Hoehler, D., Marquardt, R. R., McIntosh, A. R., and Hatch, G. M. (1997) Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by ochratoxin A and its analogues. Biochim Biophys. Acta 1357, 225-233.
60. Pfohl-Leszkowicz, A., Chakor, K., Creppy, E. E., and Dirheimer, G. (1991) DNA-adduct formation in mice treated with ochratoxin A. In Mycotoxin, Endemic Nephropathy and urinary Tract Tumours (Castegnaro, M., Pleština, R., Dirheimer, G., Chernozemsky, I. V., and Bartsch, H., Eds.) pp 245-253, IARC Sci. Publ. No. 115, Lyon.
61. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Creppy, E. E., and Dirheimer, G. (1993) Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat. Res. 289, 265-273.
62. Azémar, B., Pinelli, E., Plante, P., Escourrou, G., Petkova-Bocharova, T., and Pfohl-Leszkowicz, A. (1998) Some human kidney tumours in France exhibited a specific ochratoxin A-DNA adduct pattern. Rev. Med. Vet. 6, 653.
63. Miljkovic, A., Pfohl-Leszkowicz, A., Dobrota, M., and Mantle, P. G. (2002) Comparative responses to mode of oral administration and dose of ochratoxin A or nephrotoxic extract of Penicillium polonicum in rats. Exp. Toxicol. Pathol. 54, 305-312.
64. Petkova-Bocharova, T., Stoichev, I. T., Chernozemsky, I. N., and Pfohl-Leszkowicz, A. (1998) Formation of DNA adducts in tissues of mice progeny through transplacental contamination after administration of a single dose of ochratoxin A to the pregnant mother. Environ. Mol. Mutagen. 32, 155-162.
65. Pfohl-Leszkowicz, A., Grosse, Y., Castegnaro, M., Nicolov, I. G., Chernozemsky, I. N., Bartsch, A. M., Betbeder, A. M., Creppy, E. E., and Dirheimer, G. (1993) Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. In Postlabeling Methods for Detection of DNA Adducts (Phillips, D. H., Castegnaro, M., and Bartsch, H., Eds.) IARC Scientific Publication No. 134, Lyon, France.
66. Grosse, Y., Chekir-Ghedira, L., Hue, A., Obrecht-Pflumio, S., Dirheimer, G., Bacha, H., and Pfohl-Leszkowicz, A. (1997) Retinol, ascorbic acid and α-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone. Cancer Lett. 114, 225-229.
67. Obrecht-Pflumio, S., Grosse, Y., Pfohl-Leszkowicz, A., and Dirheimer, G. (1996) Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney. Arch. Toxicol. 70, 244-248.
68. Obrecht-Pflumio, S., and Dirheimer, G. (2000) In vitro DNA and dGMP adducts formation caused by ochratoxin A. Chem.-Biol. Interact. 127, 29-44.
69. Obrecht-Pflumio, S., and Dirheimer, G. (2001) Horseradish peroxidase mediates DNA and deoxyguanosine 3′-monophosphate adduct formation in the presence of ochratoxin A. Arch. Toxicol. 75, 583-590.
70. Dai, J., Wright, M. W., and Manderville, R. A. (2003) Ochratoxin A forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: Implications for C8 reactivity by a phenolic radical. J. Am. Chem. Soc. 125, 3716-3717.
71. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Castegnaro, M., and Manderville, R. A. (2004) Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem. Res. Toxicol. 17, 1289-1296.
72. Pfohl-Leszkowicz, A., Pinelli, E., Bartsch, H., Mohr, U., and Castegnaro, M. (1998) Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol. Carcinog. 23, 76-85.
73. Obrecht-Pflumio, S., Chassat, T., Dirheimer, G., and Marzin, D. (1999) Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes. Mutat. Res. 446, 95-102.
74. De Groene, E. M., Hassing, I. G. A. M., Blom, M. J., Seinen, W., Fink-Gremmels, J., and Horbach, G. J. (1996) Development of human cytochrome P450-expressing cell lines: Application in mutagenicity testing of ochratoxin A. Cancer Res. 56, 299-304.
75. Zepnik, H., Pahler, A., Schauer, U., and Dekant, W. (2001) Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? Toxicol. Sci. 59, 59-67.
76. Follmann, W., and Lucas, S. (2003) Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system. Arch. Toxicol. 77, 298-147.
77. Schlatter, C., Studer, R. J., and Rasonyi, T. (1996) Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit. Contam. 13 (Suppl.), 43-44.
78. O'Brien, E., and Dietrich, D. R. (2005) Ochratoxin A: The continuing enigma. Crit. Rev. Toxicol. 35, 33-60.
79. Lin, P.-H., La, D. K., Upton, P. B., and Swenberg, J. A. (2002) Analysis of DNA adducts in rats exposed to pentachlorophenol. Carcinogenesis 23, 365-369.